Hyperuricemia as a risk factor of coronary heart disease: The Framingham study

American Journal of Epidemiology

Volumn 121, Issue 1, 1985, Pages 11-18

  Brand, F N ^a   Mcgee, D L ^b   Kannel, W B ^a   Stokes, J ^a   Castelli, W P ^b  

^a BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b FRAMINGHAM HEART STUDY   (United States)

Author keywords

Cardiovascular system; Coronary disease; Uric acid

Indexed keywords

URIC ACID;

CARDIOVASCULAR SYSTEM; ETIOLOGY; FRAMINGHAM HEART STUDY; GEOGRAPHIC DISTRIBUTION; HUMAN; HYPERURICEMIA; ISCHEMIC HEART DISEASE; PRIORITY JOURNAL; RISK FACTOR; SHORT SURVEY; UNITED STATES;

AGE FACTORS; ANALYSIS OF VARIANCE; ANTIHYPERTENSIVE AGENTS; BLOOD GLUCOSE; CORONARY DISEASE; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MASSACHUSETTS; MIDDLE AGED; MYOCARDIAL INFARCTION; RISK; SEX FACTORS; TIME FACTORS; URIC ACID;

EID: 0021949147     PISSN: 00029262     EISSN: None     Source Type: Journal    
DOI: 10.1093/oxfordjournals.aje.a113972     Document Type: Article

References (45)

1. Gertler MM, Garin SM, Levine SA. Serum uric acid in relation to age and physique in health and in coronary heart disease. Ann Intern Med 1951;34:1421-31.
2. Klein R, Klein BE, Comoni JC, etal. Serum uric acid. Its relationship to coronary heart disease risk factors and cardiovascular disease, Evans County, Georgia. Ann Intern Med 1973;132:401- 10.
3. Myers AR, Epstein FH, Dodge HJ, etal. The relationship of serum uric acid to risk factors in coronary heart disease. Am J Med 1968;34:520-8.
4. Hall AP, Barry PE, Dawber TR, etal. Epidemiology of gout and hyperuricemia. Am J Med 1967;42:27-37.
5. Goulet AC. Serum uric acid: not a discriminator of coronary heart disease in men and women. Can Med ABSOC J 1973;109:986-8.
6. Kannel WB, McGee DL, Gordon TR. A general cardiovascular risk profile: the Framingham Heart Study. Am J Cardiol 1976;38:46-51.
7. Jacobson BM. The uric acid in the serum of gouty and non-gouty individuals. Determination by Folin's recent method and its significance in the diagnosis of gout. Ann Intern Med 1938;11:1277- 95.
8. The Framingham Study. An epidemiological investigation of cardiovascular disease. In: Kannel WB, Gordon T, eds. DHEW publication no (NIH)7-470, Section 29, 1973:21-22.
9. Shurtleff D. The Framingham Study. An epidemiological investigation of cardiovascular disease In: Kannel WB, Gordon T, eds. Superintendent of documents, Section 26, Washington, DC: US Government Printing Office, 1970:26-35.
10. Walker SH, Duncan DB. Estimation of the probability of an event as a function of several independent variables. Biometrika 1967;54:167-79.
11. Mantel N, Haenszel W. Statistical aspects of the analysis of data from retrospective studies of disease. J Natl Cancer Inst 1959;22:719-48.
12. Herman JB, Medalie JH, Goldbourt U. Diabetes, prediabetes and uricemia. DLabetologia 1976;12: 47-52.
13. Dollery CT, Duncan H, Schumer B. Hyperuricemia related to treatment of hypertension. Br Med J (Clin Res) 1960;l:832-5.
14. Breckenridge A. Hypertension and hyperuricemia. Lancet 1965;1:15-18.
15. Walter RD, Kissey D, Sise HS, etal. Factors influencing serum uric acid levels in patients with hypertension. Proc N Engl Cardiovasc Soc 1960:19:36.
16. Cannon PJ, Stason WB, Demartini FE, etal Hyperuricemia in primary and renal hypertension. N Engl J Med 1966;275:457-64.
17. Jacobs DR Jr, Bernstein WH. Serum uric acid: its association with other risk factors and mortality in myocardial infarction. J Chronic Dig 1976;29:557-70.
18. Yano K, Rhoads GG, Kagan A. Epidemiology of serum uric acid among 8000 Japanese-American men in Hawaii. J Chronic Dis 1977;3O:171-84.
19. Mikkelsen WM, Dodge HJ, Valdenburg H. The distribution of serum uric acid values in a population unselected as to gout or hyperuricemia: Tecumseh, Michigan, 1959-1960. Am J Med 1965;39:242-51.
20. Dodge HJ, Mikkelsen WM. Observation on the distribution of serum uric acid levels in participants of the Tecumseh, Michigan Community Health Studies. A comparison of results of one method used in two different times and of two methods used simultaneously. J Chronic Dis 1970;23:161-72.
21. Liddle L, Seegmiller JE, Laster L. The enzymatic apectrophotometric method for determination of serum uric acid. J Lab Clin Med 1959;54:903-13.
22. Technical Bulletin, Method N-A13. Chauncy, NY: Technicon Instruments Corp.
23. McLachlan MJ, Rodman GP. Effects of food, fat and alcohol on serum uric acid and acute attacks of gout. Am J Med 1967;42:38-57.
24. Lellouch J, Schwartz D, Tran MH. The relationships between smoking and levels of serum urea and uric acid. J Chronic Dis 1969;22:9-15.
25. Bosco JS, Greenleaf GE, Kaye RL, etal. Reduction of serum uric acid in young men during physical training. Am J Cardiol 1970:25:46-52.
26. Dennatini FE. Hyperuricemia induced by drugs. Arthritis Rheum 1965;8:823-9.
27. Acheson RM. Epidemiology of serum uric acid and gout: an example of the complexities of multifactorial causation. R Med Proc 1970:63:193-7.
28. Welborn TA, Cumpston GN, Cullen KJ, etal The prevalence of coronary heart disease and associated factors in an Australian rural community. Am J Epidemiol 1969:89:521-36.
29. Allard C, Goulet C. Serum uric acid: not a discriminator of coronary heart disease in men and women. Can Med Assoc J 1973; 109:986-8.
30. Fessel WJ. High uric acid as an indicator of cardiovascular disease. Independence from obesity. Am J Med 1980;68:401.
31. Takkunen H, Reunanen A. Hyperuricemia and other cardiovascular risk factors. In: Muller MM, Kaise E, Seegmiller JE, eds. Purine metabolism in man. II. Physiology, pharmacology, and clinical aspects. New York: Plenum Press, 1977:238-44.
32. Messerli FH, Frohlich ED, Dreslinski R, e al. Serum uric acid in essential hypertension: an indicator of renal vascular involvement. Ann Intern Med 1980 3:817-21.
33. Kinsey D, Walther R, Sise HS, etal. Incidence of hyperuricemia in 400 hypertension patients. Circulation 1961;24:972-3.
34. Sive PH, Medalie JH, Kahn HA, etal. Distribution and multiple regression analysis of blood pressure in 10, 000 Israeli men. Am J Epidemiol 1971:93:317-27.
35. Zalokar J, Lellouch J, Claude JR, etal. Epidemiology of serum uric acid and gout in Frenchmen. J Chronic Dis 1974;27:59-75.
36. Bulprit CJ. Serum uric acid in hypertensive patients. Br Heart J 1975;37:121O-15.
37. Editorial. Diuretics, hyperuricemia and tienilic acid. Lancet 1980;2:681-2.
38. Bengtsson C. Elevated serum uric acid levels during treatment with antihypertensive drugs. Acta Med Scand (Suppl) 1979;628:69-71.
39. Reunanen A, Takkunen H, Knekt P, et aL Hyperuricemia as a risk factor for cardiovascular mortality. Acta Med Scand (Suppl) 1982;668:49-59.
40. Mikkelsen WM. The possible associations of hyperuricemia and/or gout with diabetes mellitus. Arthritis Rheum 1965;8:853-9.
41. Benedek TG. Correlations of serum uric acid and lipid concentrations in normal, gouty and atherosclerotic men. Ann Intern Med 1967;66:851-61.
42. Wilson PW, McGee DL, Kannel WB. Obesity, very low density lipoproteins, and glucose intolerance over fourteen years. The Framingham Study. Am J Epidemiol 1981;114:697-704.
43. Berkowitz D. Gout, hyperlipidemia and diabetes interrelationships. JAMA 1966;197:117-20.
44. Herman JB, Medalie JH, Groen JJ, etal. Diabetes prevalence and serum uric acid. Observations among 10, 000 men in a survey of ischemic heart disease in Israel. Diabetes 1967;16:858-68.
45. Herman JB, Goldbourt U. Uric acid and diabetes: observations in a population study. Lancet 1982:2:240-3.